Il-17 inhibitor in patient with juvenile psoriasis and primary immunodeficiency

被引：0
|
作者：
Sestan, Mario [1 ]
Frkovic, Marijan [1 ]
Ceovic, Romana [2 ]
Murat-Susic, Slobodna [2 ]
Jelusic, Marija [1 ]
机构：
[1] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Paediat, Zagreb, Croatia
[2] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Dermatol & Venerol, Zagreb, Croatia
来源：
PEDIATRIC ALLERGY AND IMMUNOLOGY | 2024年 / 35卷 / 01期
关键词：
CLASSIFICATION; SECUKINUMAB; AUTOIMMUNE;
D O I：
10.1111/pai.14074
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Cellular sources of IL-17 in psoriasis: a paradigm shift?
    Keijsers, Romy R. M. C.
    Joosten, Irma
    van Erp, Piet E. J.
    Koenen, Hans J. P. M.
    van de Kerkhof, Peter C. M.
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (11) : 799 - 803
  • [42] Brodalumab: A new way to inhibit IL-17 in psoriasis
    Facheris, Paola
    Valenti, Mario
    Pavia, Giulia
    Guanziroli, Elena
    Narcisi, Alessandra
    Borroni, Riccardo G.
    Costanzo, Antonio
    DERMATOLOGIC THERAPY, 2020, 33 (03)
  • [43] Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis
    Durham, L. E.
    Kirkham, B. W.
    Taams, L. S.
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (08)
  • [44] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [45] IL-17 SIGNALING IN PRIMARY SCLEROSING CHOLANGITIS PATIENT-DERIVED ORGANOIDS
    Moreno, Ana Sofia Garcia
    Gores, Gregory J.
    Guicciardi, Maria Eugenia
    Jessen, Erik
    Wixom, Alexander Q.
    Vairo, Filippo Pinto E.
    Yang, Jingchun
    Ilyas, Sumera I.
    Bianchi, Jackie K.
    Lazaridis, Konstantinos N.
    HEPATOLOGY, 2023, 78 : S1778 - S1778
  • [46] IL-17 signaling in primary sclerosing cholangitis patient-derived organoids
    Moreno, Ana S. Garcia
    Guicciardi, Maria E.
    Wixom, Alexander Q.
    Jessen, Erik
    Yang, Jingchun
    Ilyas, Sumera I.
    Bianchi, Jackie K.
    Vairo, Filippo
    Lazaridis, Konstantinos N.
    Gores, Gregory J.
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (06)
  • [47] SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor
    Balestri, R.
    Rech, G.
    Girardelli, C. R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (08) : E357 - E358
  • [48] Are new variants of psoriasis therapy (IL-17 inhibitors) safe?
    Wcislo-Dziadecka, Dominika
    Kazmierczak, Agata
    Grabarek, Beniamin
    Zbiciak-Nylec, Martyna
    Brzezinska-Wcislo, Ligia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (12) : 1360 - 1365
  • [49] In-depth characterization of the expression of IL-17 isoforms in psoriasis
    Senra, L.
    Stalder, R.
    Boehncke, W.
    Brembilla, N. C.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E7 - E7
  • [50] IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia
    Gardner, Louis C. S.
    Grantham, Henry J.
    Reynolds, Nick J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (06) : 1214 - 1216
12345